Nikolai Eroshenko

Eroshenko Nikolai

HelixNano

CSO

Nikolai is a co-founder of HelixNano, a Y Combinator and venture backed biotech startup focused on developing next-generation non-viral gene therapy technologies. His graduate and post-doctoral work was done in George Church’s laboratory at Harvard Medical School, where he both led the effort to adapt site-specific recombinases for gene delivery application, and co-invented a novel approach for inexpensive gene synthesis. Nikolai received a BSc in Biomedical Engineering from Virginia Commonwealth University and a PhD from Harvard University in Bioengineering.